Postdoctoral Research Scientist

The Beatson Institute for Cancer Research

Prof Martin Bushell

Starting Salary from £30,000 to £39,800 (Depending on experience) plus relocation allowance. Initial 3 year fixed term contract (with possibility of up to 2 years’ extension).

Would you like to develop your scientific career in a research institute that is founded on the quality of its people and designed to promote the development of the most outstanding and dedicated scientists?  Many early career researchers have already made that decision and at present over 100 of them are now benefiting from our excellent training programme. 

The Cancer Research UK Beatson Institute supports cutting edge research into the molecular mechanisms of cancer development and is one of the leading research institutes in Europe. The Institute provides an outstanding research environment, underpinned by state-of-the-art core services and advanced technologies, with special emphasis on imaging, metabolomics, and in vivo models.

A research position is available within the laboratory of Prof. Bushell as part of an exciting new academic alliance between RNA biologists in UK and CRUK’s Therapeutic Discovery laboratories to develop novel cancer therapies to the translational control apparatus. In this alliance, RBP targets and translational control components are to be identified and validated in the participating academic labs, namely MRC Leicester, the Beatson Institute in Glasgow, the Babraham Institute in Cambridge and the Department of Oncology, Oxford. Drug development will then be conducted at the Beatson Drug Discovery Unit and the CRUK Therapeutic Discovery laboratories and accompanying bench-to-bedside assays will be developed in the academic centres. Successful agents will enter clinical evaluation in Oxford’s Early Phase Trials Unit, one of the largest centres for clinical drug development in the UK. This post is an opportunity to join the Bushell lab at the Beatson Institute and identify and validate new and existing targets. The post is truly translational; the post-holder will be working alongside clinicians and technicians to explore biology of targets, identify relevant patient populations that will derive benefit and assist in the early steps of biomarker development. They will work with the wider alliance and collaborate with CRUK in this innovative initiative. The Bushell lab has strong track-record of expertise in translational control research in cancer, having characterised the differential roles of eIF4As.

Applicants must have a PhD in a relevant field, be driven by scientific curiosity, and have an excellent publication record in cell biology. Experience with in vivo models of cancer, biochemical kinetic assays using recombinant purified proteins will be an advantage.

The Cancer Research UK Beatson Institute is committed to increase the number of female scientists at this level and encourages female applicants to apply.

For informal enquiries please email Prof Bushell at

All applications must be made via our website at

Closing Date for Applications: 23 February 2018

Share this job
  Share by Email   Print this job   More sharing options
We value your feedback on the quality of our adverts. If you have a comment to make about the overall quality of this advert, or its categorisation then please send us your feedback
Advert information

Type / Role: